Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias

Area of Science:

• Biochemistry
• Neurology
• Biomarker Discovery

Background:

• Neurodegenerative dementias involve protein misfolding and neuronal network breakdown.
• Current biomarkers primarily target specific diseases like Alzheimer's, lacking coverage for co-pathologies.
• Biofluid biomarkers are crucial for precision medicine, understanding disease mechanisms, and clinical trial development.

Purpose of the Study:

• To review available technologies for discovering novel biofluid-based biomarkers for neurodegenerative dementias.
• To provide a comprehensive lexicon of current technologies used in research and clinical settings.
• To guide researchers and clinicians in selecting appropriate technologies based on their strengths and limitations.

Main Methods:

• Literature review of existing technologies for biofluid biomarker analysis.
• Categorization of technologies based on their application in research and clinical practice.
• Analysis of the strengths, limitations, and future perspectives of each technology.

Main Results:

• An overview of various technologies for detecting protein biomarkers in body fluids.
• Discussion on the utility of each technology in different research and clinical contexts.
• Identification of gaps and future directions in biofluid biomarker technology development.

Conclusions:

• The choice of technology is critical for successful biofluid biomarker discovery in dementia.
• A comprehensive understanding of available technologies is needed to advance precision medicine for neurodegenerative diseases.
• Further development and validation of diverse biomarker technologies are essential for improved dementia diagnosis and treatment.